Biochemistry Research International

Biochemistry Research International / 2015 / Article

Research Article | Open Access

Volume 2015 |Article ID 175950 |

Ganiyu Oboh, Adedayo O. Ademiluyi, Ayokunle O. Ademosun, Tosin A. Olasehinde, Sunday I. Oyeleye, Aline A. Boligon, Margareth L. Athayde, "Phenolic Extract from Moringa oleifera Leaves Inhibits Key Enzymes Linked to Erectile Dysfunction and Oxidative Stress in Rats’ Penile Tissues", Biochemistry Research International, vol. 2015, Article ID 175950, 8 pages, 2015.

Phenolic Extract from Moringa oleifera Leaves Inhibits Key Enzymes Linked to Erectile Dysfunction and Oxidative Stress in Rats’ Penile Tissues

Academic Editor: Emanuel Strehler
Received28 Jul 2015
Accepted09 Sep 2015
Published05 Oct 2015


This study was designed to determine the antioxidant properties and inhibitory effects of extract from Moringa oleifera leaves on angiotensin-I-converting enzyme (ACE) and arginase activities in vitro. The extract was prepared and phenolic (total phenols and flavonoid) contents, radical (nitric oxide (NO), hydroxyl (OH)) scavenging abilities, and Fe2+-chelating ability were assessed. Characterization of the phenolic constituents was done via high performance liquid chromatography-diode array detection (HPLC-DAD) analysis. Furthermore, the effects of the extract on Fe2+-induced MDA production in rats’ penile tissue homogenate as well as its action on ACE and arginase activities were also determined. The extract scavenged , , chelated Fe2+, and inhibited MDA production in a dose-dependent pattern with IC50 values of 1.36, 0.52, and 0.38 mg/mL and 194.23 µg/mL, respectively. Gallic acid, chlorogenic acid, quercetin, and kaempferol were the most abundant phenolic compounds identified in the leaf extract. The extract also inhibited ACE and arginase activities in a dose-dependent pattern and their IC50 values were 303.03 and 159.59 µg/mL, respectively. The phenolic contents, inhibition of ACE, arginase, and Fe2+-induced MDA production, and radical (, ) scavenging and Fe2+-chelating abilities could be some of the possible mechanisms by which M. oleifera leaves could be used in the treatment and/or management of erectile dysfunction.

1. Introduction

Previous reports have revealed that erectile dysfunction (ED) is prevalent in over 150 million men all over the world and has been predicted to affect about 250 million men by 2025 [1]. Normal erectile function is stimulated through a series of actions involving the relaxation of cavernosal arteries and sinuses which leads to increase in blood flow to the penis [2]. These actions are mediated by nitric oxide via the activation of nitric oxide- (NO-) cyclic guanosine monophosphate (cGMP) dilator pathway and can be impaired by different factors thereby causing ED [2]. Increased arginase activity has been implicated in ED. Arginase is a metalloenzyme that converts arginine to urea and ornithine in a number of cells. There are also growing evidences that ED can be induced by high blood pressure via inveterate changes in blood pressure which can alter the flow of blood in penile vessels [3]. Moreover, angiotensin II which is obtained from angiotensin I in a reaction catalysed by angiotensin-I-converting enzyme is a potent vasoconstrictor capable of inducing vascular hypertrophy and endothelial dysfunction via decrease in the release of NO [4]. Likewise, ACE deactivates bradykinin, a vasodilator which has been implicated in erectile function via the release of NO and relaxation of corpus cavernosum [5]. The conversion of angiotensin I to angiotensin II and deactivation of bradykinin can induce high blood pressure which in turn impairs erectile function.

Oxidative stress has been linked with ED due to excessive generation of free radicals in the cavernosal tissues [6]. Superoxide combines with nitric oxide (NO) to form highly toxic peroxynitrite which is known to induce lipid peroxidation. Oxidative stress in ED reduces the availability of NO which is required for penile erection [6]. Recent trends in the management of ED involve increase in NO levels with the use of arginase inhibitors. This is because in ED there are elevated levels of arginase activity which limits NO synthase activity, reduces NO biosynthesis, and increases degradation of arginine. Antioxidants are capable of reducing oxidative stress by scavenging free radicals. Polyphenols are the most abundant antioxidants in human diet and are widespread constituents of fruits and vegetable [7]. Several studies have shown various relationships between the consumption of polyphenol or polyphenol-rich foods and diseases such as ED, diabetes, and cardiovascular and neurodegenerative diseases [8].

Moringa oleifera Lam. (Moringaceae) commonly known as drum stick is a medicinal plant widely grown in the tropical and subtropical regions. Reports have shown that M. oleifera leaves possess various pharmacological properties such as antiatherosclerosis, anti-inflammatory, antihypertensive, and antioxidant effects [9, 10]. However, there is dearth of information on the possible mechanism of action of M. oleifera leaf extracts with respect to penile function and the ability of the leaves to protect the penis against Fe2+-induced lipid peroxidation. This study was designed to investigate the inhibitory effects of aqueous extract from Moringa oleifera leaves on key enzymes linked to ED (ACE and arginase) and its antioxidant potential.

2. Materials and Methods

2.1. Sample Collection

Moringa oleifera leaves were purchased from the Akure main market, Akure, Nigeria, and authenticated at the Department of Crop and Pest Management, Federal University of Technology, Akure, Nigeria. The M. oleifera leaves were air dried at room temperature and pulverized. Unless otherwise stated, all other chemicals and reagents used were of analytical grades and the water was glass distilled. A Jenway UV-visible spectrophotometer (Model 6305; Jenway, Barlo World Scientific, Dunmow, United Kingdom) was used to measure absorbance.

2.2. Phenolic Extraction

Powdered sample (5 g) was soaked in 100 mL of distilled water for about 24 h at 37°C. The mixture was filtered and centrifuged at 4000 rev/min for 10 min to obtain a clear supernatant which was used for subsequent analysis.

2.3. High Performance Liquid Chromatography-Diode Array Detector (HPLC) Analysis

Chromatographic analyses were carried out under gradient conditions using C18 column (4.6 mm × 150 mm) packed with 5 μm diameter particles; the mobile phase was water containing 1% formic acid (A) and acetonitrile (B), and the composition gradient was 13% of B until 10 min and changed to obtain 20, 30, 50, 60, 70, 20, and 10% B at 20, 30, 40, 50, 60, 70, and 80 min, respectively [11]. Moringa oleifera leaf extract and mobile phase were filtered through 0.45 μm membrane filter (Millipore) and then degassed by ultrasonic bath prior to use; the extract was analyzed at a concentration of 20 mg/mL. The flow rate was 0.7 mL/min, injection volume was 40 μL, and the wavelength was 254 nm for gallic acid, 280 nm for catechin and epicatechin, 325 nm for chlorogenic and ellagic acids, and 365 nm for quercetin, quercitrin, isoquercitrin, rutin, and kaempferol. Stock solutions of standards references were prepared in the HPLC mobile phase at a concentration range of 0.030–0.250 mg/mL for kaempferol, quercetin, quercitrin, isoquercitrin, rutin, catechin, and epicatechin and 0.050–0.450 mg/mL for ellagic, gallic, and chlorogenic acids. Chromatography peaks were confirmed by comparing their retention time with those of reference standards and by DAD spectra (200–500 nm).

2.4. Determination of Total Phenol Content

The total phenol content of the extract was determined as described by Singleton et al. [12]. Briefly, appropriate dilution of the extracts was oxidized with 2.5 mL 10% Folin-Ciocalteu’s reagent (v/v) and neutralized by 2.0 mL of 7.5% NaCO3. The reaction mixture was incubated for 40 min at 45°C and the absorbance was measured at 765 nm in the spectrophotometer. Gallic acid was used as standard and the total phenol content was subsequently calculated as gallic acid equivalent.

2.5. Determination of Total Flavonoid Content

The total flavonoid content was determined using a slightly modified method [13]. Briefly, 0.5 mL of appropriate diluted extract was mixed with 0.5 mL of methanol, 50 μL of 10% AlCl3, 50 μL of 1 M potassium acetate, and 1.4 mL H2O. The mixture was incubated at room temperature for 30 min. Thereafter, the absorbance of the reaction mixture was subsequently measured at 415 nm. Quercetin was used as standard and the total flavonoid content was calculated as quercetin equivalent.

2.6. Nitric Oxide Scavenging Activity

Nitric oxide scavenging assay was performed using Griess reagent method [14]. Briefly, 0.3 mL of sodium nitroprusside (5 mM) was added to 1 mL of each of various concentrations of the extract. The tubes were then incubated at 25°C for 150 min. After 150 min, 0.5 mL of Griess reagent (equal volume of 1% sulphanilamide on 5% orthophosphoric acid and 0.01% naphthyl ethylenediamine in distilled water, used after 12 h of preparation) was added. The absorbance was measured at 546 nm.

2.7. Hydroxyl Radical Scavenging Ability

The method of Halliwell and Gutteridge [15] was used to determine the ability of the extract to prevent Fe2+/H2O2-induced decomposition of deoxyribose. The extract 0–100 μL was added to a reaction mixture containing 120 μL of 20 mg deoxyribose, 400 μL of 0.1 M phosphate buffer, and 40 μL of 500 μM of Fe2SO4, and the volume was made up to 800 μL with distilled water. The reaction mixture was incubated at 37°C for 30 min and the reaction was then stopped by the addition of 0.5 mL of 28% trichloroacetic acid. This was followed by addition of 0.4 mL of 0.6% thiobarbituric acid solution. The tubes were subsequently incubated in boiling water for 20 min. The absorbance was measured at 532 nm in a spectrophotometer.

2.8. Fe2+ Chelation Assay

The Fe2+-chelating ability of the extracts was determined using a slightly modified method [16, 17]. Freshly prepared 500 μM FeSO4 (150 μL) was added to a reaction mixture containing 168 μL of 0.1 M Tris-HCl (pH 7.4), 218 μL of saline (0.9%), and the extracts (0–25 μL). The reaction mixture was incubated for 5 min, before the addition of 13 μL 0.25% 1,10-phenanthroline (w/v). The absorbance was subsequently measured at 510 nm in a spectrophotometer. The Fe(II)-chelating ability was subsequently calculated.

2.9. Preparation of Penile Tissue Homogenate

The rats were decapitated under mild diethyl ether anesthesia and rapidly dissected. The penile tissues were removed and placed on ice and weighed. These tissues were subsequently homogenized in cold saline (1/10 w/v) with about 10-up-and-down strokes at approximately 1200 rev/min in a Teflon glass homogenizer. The homogenate was centrifuged for 10 min at 3000 ×g to yield a pellet that was discarded and a low-speed supernatant (S1) that was kept for lipid peroxidation assay.

2.10. Lipid Peroxidation and Thiobarbituric Acid Reactions Assay

Hundred micro liters (100 μL) of penile homogenate supernatant was mixed with a mixture containing 30 μL of 0.1 M Tris-HCl buffer (pH 7.4), extract (0–100 μL), and 30 μL of the prooxidant (250 μM iron(II) sulphate). The volume was made up with 300 μL of distilled water before incubation at 37°C for 2 h. The colour reaction was developed by adding 300 μL of 8.1% SDS (sodium dodecyl sulphate) to the reaction mixture containing the homogenate, followed by the addition of 600 μL of acetic acid/HCl (pH 3.4) and 600 μL of 0.8% thiobarbituric acid (TBA). This mixture was incubated at 100°C for 1 h. The absorbance of thiobarbituric acid reactive species (TBARS) produced was measured at 532 nm. MDA (malondialdehyde) produced was expressed as % control [18, 19].

2.11. Angiotensin-I-Converting Enzyme (ACE) Inhibition Assay

The inhibition of ACE activity of the extract was determined according to the described method of Cushman and Cheung [20]. Different concentrations of the extract and 50 μL of rabbit lungs ACE (EC solution (4 mU/mL) were preincubated at 37°C for 15 min. Thereafter, enzymatic reaction was initiated by adding 150 μL of 8.33 mM ACE substrate [hippuryl-l-histidyl-l-leucine (HHL)] in 125 mM of Tris-HCl buffer (pH 8.3) to the reaction mixture and incubated at 37°C for 30 min. The reaction was stopped by adding 250 μL of 1 M HCl. The hippuric acid (Bz-Gly) produced by the reaction was extracted with 1.5 mL ethyl acetate. The mixture was then centrifuged to separate the ethyl acetate layer, after which the 1 mL of the ethyl acetate layer was transferred to a clean test tube and evaporated to dryness. The residue was redissolved in distilled water and its absorbance was measured at 228 nm. The average value from three determinations of each concentration was used to calculate the ACE inhibition at concentration between 1.25 and 6.30 μg/mL which was used as control.

2.12. Arginase Inhibition Assay

Penile homogenates were prepared by homogenizing 10 g (w/v) of penile tissue in three volumes of homogenization cold buffer (phosphate buffer, pH 7.2). The homogenate was centrifuged for 20 min at 4000 r.p.m and the supernatant was used as the source of enzyme. Arginase activity was determined by the measurement of urea produced by the reaction of Ehrlich’s reagent. The reaction mixture contained in final concentration 1.0 mM Tris-HCl buffer, pH 9.5, containing 1.0 mM MnCl 0.1 M arginine solution and 50 mM of the enzyme preparation in a final volume of 1.0 mL. The mixture was incubated for 10 min at 37°C. The reaction was terminated by the addition of 2.5 mL Ehrlich reagent (2.0 g of p-dimethylaminobenzaldehyde in 20 mL of concentrated hydrochloric acid and made up to 100 mL with distilled water). The optical density reading was taken after 20 min at 450 nm. The control experiment was performed without the test sample and the arginase inhibitory activity was expressed as percentage inhibition [21].

2.13. Data Analysis

The results of three replicates were pooled and expressed as mean ± standard deviation (S.D.). Student’s -test, one-way analysis of variance (ANOVA), and least significance difference (LSD) were carried out [22]. Significance was accepted at . IC50 was determined using nonlinear regression analysis.

3. Results

3.1. Phenolic Profile

The HPLC-DAD analysis as presented in Table 1 and Figure 1 revealed the presence of phenolic compounds such as gallic acid (105.67 mg/g), catechin (20.19 mg/g), chlorogenic acid (79.31 mg/g), and ellagic acid (52.95 mg/g) and flavonoids such as quercetin (137.81 mg/g), quercitrin (74.9 mg/g), isoquercitrin (75.65 mg/g), kaempferol (106.75 mg/g), and rutin (60.38 mg/g). The results of the total phenol and flavonoid contents of the M. oleifera leaf extract are presented in Table 2. The total phenolic content reported as gallic acid equivalent was 15.2 mgGAE/100 g, while the total flavonoid content reported as quercetin equivalent was 3.1 mgQUE/100 g.


Gallic acid105.67 ± 0.0110.56
Catechin20.19 ± 0.032.01
Chlorogenic acid79.31 ± 0.027.93
Ellagic acid52.95 ± 0.025.29
Epicatechin29.73 ± 0.012.97
Rutin60.38 ± 0.026.03
Quercitrin74.90 ± 0.017.49
Isoquercitrin75.65 ± 0.027.56
Quercetin137.81 ± 0.0113.78
Kaempferol106.75 ± 0.0310.67

Values represent means ± standard deviation of triplicate readings.

Parameter (unit)Value

Total phenol (gallic acid equivalent) (mg/100 g)15.2 ± 1.6
Total flavonoid (quercetin equivalent) (mg/100 g)3.1 ± 0.1

Values represent means ± standard deviation of triplicate readings.
3.2. Radical Scavenging Ability

The phenolic extract dose-dependently scavenged and as shown in Figures 2 and 3, respectively. IC50 values are 0.52 mg/mL () and 1.36 mg/mL () (Table 3).


NO scavenging ability (mg/mL)1.36 ± 0.09
OH scavenging ability (mg/mL)0.52 ± 0.07
Fe2+-chelating ability (mg/mL)0.38 ± 0.08
Inhibition of Fe2+-induced lipid peroxidation (µg/mL)194.23 ± 2.31
Inhibition ACE activity (µg/mL)303.03 ± 3.45
Inhibition of arginase activity (µg/mL)159.59 ± 2.14

Values represent means ± standard deviation of triplicate readings.
3.3. Fe2+-Chelating Ability

Figure 4 shows the Fe2+-chelating ability of the phenolic extract from M. oleifera. The extract was able to chelate Fe2+ in a dose-dependent manner with IC50 = 0.38 mg/mL as shown in Table 3.

3.4. Inhibition of Malondialdehyde Production

The incubation of penile tissue homogenates in the presence of Fe2+ caused a significant increase () in the malondialdehyde (MDA) content (120.58%) as shown in Figure 5. However, the phenolic extract from M. oleifera leaves inhibited MDA levels in a dose-dependent manner with IC50 value of 194.23 μg/mL (Table 3).

3.5. Effects of Phenolic Extract from M. oleifera Leaves on ACE and Arginase Activities

The interaction of phenolic extract with ACE as shown in Figure 6 revealed that the phenolic extract from M. oleifera leaves inhibited ACE activity in vitro in a dose-dependent pattern with IC50 of 303.03 μg/mL. Furthermore, the result in Figure 7 revealed that the phenolic extract inhibited arginase activity in a dose-dependent manner with IC50 = 159.59 μg/mL (Table 3).

4. Discussion

M. oleifera is known to have various medicinal benefits and these have been attributed to its phytochemicals such as phenolic compounds [10, 23]. These phytochemicals are capable of causing definite physiological actions in human body. Reports have revealed that phenolic contents of medicinal plants are related to their antioxidant capacity [24]. The result obtained in this study shows that the phenolic extract from M. oleifera leaves exhibited hydroxyl (OH) and nitric oxide (NO) radicals scavenging abilities. Hydroxyl radical (OH) is mainly generated in biological systems from superoxide anion and hydrogen peroxide by the Haber-Weiss reaction or from hydrogen peroxide via the Fenton reaction [25]. Hydroxyl radical () is highly reactive, energetic, short-lived, and very toxic to cells [26]. Studies have revealed that reactive species such as hydroxyl radicals () play an important role in the diabetes-related ED [27, 28]. The scavenging ability of the M. oleifera leaf extract could be attributed to the presence of polyphenols which are capable of donating hydrogen atoms to OH radicals, thus inhibiting the oxidation process [29]. Nitric oxide radical (), generated by the inducible form of nitric oxide synthase (NOS) in response to inflammation, mediates many cytotoxic and pathological processes and could contribute in part to the formation of plaque in penile tissues [30]. Although NO is required for the initiation of erection by mediation of the relaxation of corpus cavernosum smooth muscles and penile tissues, it can also combine with superoxide () to form peroxynitrite. The interaction between NO and reactive oxygen species (ROS) is central to the pathophysiology of ED [31]. Peroxynitrite is cytotoxic and contributes to lipid peroxidation and nitration which leads to the formation of malondialdehyde and hydroperoxides [32]. Although peroxynitrite causes smooth-muscle relaxation, it also increases the incidence of apoptosis in the endothelium and decreases the synthesis and bioavailability of NO [33]. Therefore, the scavenging ability of the M. oleifera leaf extract as revealed in this study could be beneficial in the management of erectile dysfunction. Hence, augmenting the body’s antioxidant status could be a practical approach by which oxidative stress-induced erectile dysfunction can be managed.

The disruption of iron balance in the body system can bring about iron overload which is associated with oxidative stress-induced ED [34]. Iron overload increases the formation of reactive oxygen species (ROS) which induces the initiation of lipid peroxidation [35]. Iron II (Fe2+) reacts with H2O2 in the Fenton reaction to produce the highly reactive hydroxyl radical, which can damage proteins, lipids, and nucleic acids. Our findings revealed that phenolic extract from M. oleifera leaves was able to chelate Fe2+ in a dose-dependent manner. This chelating ability might be due to the presence of some phytochemicals such as polyphenols. Phenolic compounds can form a complex with iron thereby aiding its excretion from the body. Fe2+-chelating ability of M. oleifera leaf extract could therefore be beneficial in the management/prevention of erectile dysfunction [36]. Moreover, Akomolafe et al. [37] suggested phenolic compounds such as gallic acid, chlorogenic acid, catechin, kaempferol, quercetin, and quercitrin are capable of interfering with iron metabolism thereby chelating the metallic ion.

Superoxide anions and other reactive oxygen species have been shown to be a major contributor to the pathogenesis of erectile dysfunction via the initiation of lipid peroxidation [38, 39]. Increase in malondialdehyde (MDA) content when rat penile tissue homogenate was incubated in the presence of Fe2+ could be through the breakdown of hydrogen peroxide to generate [40]. Fe2+-induced lipid peroxidation in the cell membrane induces oxidative stress, reduces antioxidant enzymes, and causes injuries to the penile tissues [41]. According to Jia et al. [42] oxidative damage can occur in the DNA via peroxidative breakdown of membrane polyunsaturated fatty acids. DNA damage affects homeostasis of various cells leading to cell death [43]. However, the inhibition of MDA production caused by the extract from M. oleifera leaves could be attributed to the ability of the extract to chelate Fe2+ and scavenged radicals thus preventing the initiation of oxidative damage [39].

Some experimental investigations have revealed that increase in blood pressure may be associated with erectile dysfunction [44]. Therefore inhibition of angiotensin-I-converting enzyme which catalyses the conversion of angiotensin I to angiotensin II has marked effects on lowering the blood pressure thereby activating the release of NO which improves erectile function. Furthermore, the inhibition of ACE activates bradykinin which has been implicated in erectile function [5, 44]. ACE inhibitors have a valuable role to play in patients who have hypertension and erectile dysfunction. The observed inhibitory effects of the phenolic extract from M. oleifera leaves on ACE activity could be linked to the phenolic constituents and this could contribute to erectile function. Previous report has shown that phenolics can interact with disulphide bridges present on the surface of the enzyme thereby modifying the structure and reducing its activity [45].

Decrease in NO bioavailability due to endothelial dysfunction or nerve injury is a major predisposing factor for erectile dysfunction [45]. An increased level of arginase is common in patients with ED due to decrease in nitric oxide synthase (NOS) activity and impairment in the biosynthesis of nitric oxide (NO) via the NO-cGMP pathway [46]. Thus, dose-dependent inhibition of arginase activity by the M. oleifera leaf extract could be of immense importance in the management of ED as this would increase genital blood flow during sexual arousal. The inhibitory properties of the phenolic extract from M. oleifera leaves could be attributed to the phenolic components. Polyphenols have been reported to possess inhibitory effects on arginase activity [47, 48]. Furthermore, flavonoids such as catechin, epicatechin, and quercetin and its derivatives (quercitrin and isoquercitrin) have shown to be strong inhibitors of arginase activity and could be linked to the formation of hydrogen bond and hydrophobic interactions between these polyphenolic compounds and the hydrophobic active site of the enzyme [47, 48].

5. Conclusion

The antioxidant properties and ACE and arginase inhibitory effects of phenolic extract from M. oleifera leaves suggest that this plant has a therapeutic potential in the management of erectile dysfunction. These findings also revealed the possible mechanism of action of the M. oleifera leaf in the management/treatment of ED. However, this health promoting effect is suggested to be a function of its phenolic and flavonoid contents.

Conflict of Interests

The authors declare no conflict of interests regarding this paper.


  1. I. A. Aytaç, J. B. McKinlay, and R. J. Krane, “The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences,” BJU International, vol. 84, no. 1, pp. 50–56, 1999. View at: Publisher Site | Google Scholar
  2. K. E. Andersson and G. Wagner, “Physiology of penile erection,” Physiological Reviews, vol. 75, pp. 191–236, 1995. View at: Google Scholar
  3. R. Rosalba de Mendonça, F. Korkes, and J. P. Zambon, “Erectile dysfunction etiological factors,” in Erectile Dysfunction—Disease-Associated Mechanisms and Novel Insights into Therapy, K. Nunes, Ed., InTech, 2012. View at: Publisher Site | Google Scholar
  4. J.-V. Mombouli and P. M. Vanhoutte, “Endothelial dysfunction: from physiology to therapy,” Journal of Molecular and Cellular Cardiology, vol. 31, no. 1, pp. 61–74, 1999. View at: Publisher Site | Google Scholar
  5. C. E. Teixeira, R. A. Moreno, U. Ferreira et al., “Pharmacological characterization of kinin-induced relaxation of human corpus cavernosum,” British Journal of Urology, vol. 81, no. 3, pp. 432–436, 1998. View at: Publisher Site | Google Scholar
  6. J. Y. Jeremy, G. D. Angelini, M. Khan et al., “Platelets, oxidant stress and erectile dysfunction: an hypothesis,” Cardiovascular Research, vol. 46, no. 1, pp. 50–54, 2000. View at: Publisher Site | Google Scholar
  7. G. Oboh and J. B. T. Rocha, “Distribution and antioxidant activity of polyphenols in ripe and unripe tree pepper (Capsicum pubescens),” Journal of Food Biochemistry, vol. 31, no. 4, pp. 456–473, 2007. View at: Publisher Site | Google Scholar
  8. A. Ferreira, C. Proença, M. L. M. Serralheiro, and M. E. M. Araújo, “The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal,” Journal of Ethnopharmacology, vol. 108, no. 1, pp. 31–37, 2006. View at: Publisher Site | Google Scholar
  9. P. Chumark, P. Khunawat, Y. Sanvarinda et al., “The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam. leaves,” Journal of Ethnopharmacology, vol. 116, no. 3, pp. 439–446, 2008. View at: Publisher Site | Google Scholar
  10. A. R. Verma, M. Vijayakumar, C. S. Mathela, and C. V. Rao, “In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves,” Food and Chemical Toxicology, vol. 47, no. 9, pp. 2196–2201, 2009. View at: Publisher Site | Google Scholar
  11. J. P. Kamdem, E. O. Olalekan, W. Hassan et al., “Trichilia catigua (Catuaba) bark extract exerts neuroprotection against oxidative stress induced by different neurotoxic agents in rat hippocampal slices,” Industrial Crops and Products, vol. 50, pp. 625–632, 2013. View at: Publisher Site | Google Scholar
  12. V. L. Singleton, R. Orthofer, and R. M. Lamuela-Raventós, “Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent,” Methods in Enzymology, vol. 299, pp. 152–178, 1998. View at: Publisher Site | Google Scholar
  13. A. Meda, C. E. Lamien, M. Romito, J. Millogo, and O. G. Nacoulma, “Determination of the total phenolic, flavonoid and proline contents in Burkina Fasan honey, as well as their radical scavenging activity,” Food Chemistry, vol. 91, no. 3, pp. 571–577, 2005. View at: Publisher Site | Google Scholar
  14. S. Samajdar, F. F. Becker, and B. K. Banik, “Surface-mediated highly efficient regioselective nitration of aromatic compounds by bismuth nitrate,” Tetrahedron Letters, vol. 41, no. 42, pp. 8017–8020, 2000. View at: Publisher Site | Google Scholar
  15. B. Halliwell and J. M. C. Gutteridge, “Formation of a thiobarbituric-acid-reactive substance from deoxyribose in the presence of iron salts,” FEBS Letters, vol. 128, no. 2, pp. 347–352, 1981. View at: Publisher Site | Google Scholar
  16. G. Minotti and S. D. Aust, “An investigation into thee mechanism of citrate Fe2+-dependent lipid peroxidation,” Free Radical Biology and Medicine, vol. 3, no. 6, pp. 379–387, 1987. View at: Publisher Site | Google Scholar
  17. R. L. Puntel, C. W. Nogueira, and J. B. T. Rocha, “Krebs cycle intermediates modulate thiobarbituric acid reactive species (TBARS) production in rat brain in vitro,” Neurochemical Research, vol. 30, no. 2, pp. 225–235, 2005. View at: Publisher Site | Google Scholar
  18. E. M. S. Belle, L. Duret, N. Galtier, and A. Eyre-Walker, “The decline of isochores in mammals: an assessment of the GC content variation along the mammalian phylogeny,” Journal of Molecular Evolution, vol. 58, no. 6, pp. 653–660, 2004. View at: Google Scholar
  19. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at: Publisher Site | Google Scholar
  20. D. W. Cushman and H. S. Cheung, “Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung,” Biochemical Pharmacology, vol. 20, no. 7, pp. 1637–1648, 1971. View at: Publisher Site | Google Scholar
  21. G. A. Kaysen and H. J. Strecker, “Purification and properties of arginase of rat kidney,” Biochemical Journal, vol. 133, no. 4, pp. 779–788, 1973. View at: Publisher Site | Google Scholar
  22. J. H. Zar, Bio Statistical Analysis, Prentice-Hall, Englewood Cliffs, NJ, USA, 1984.
  23. B. Vongsak, P. Sithisarn, S. Mangmool, S. Thongpraditchote, Y. Wongkrajang, and W. Gritsanapan, “Maximizing total phenolics, total flavonoids contents and antioxidant activity of Moringa oleifera leaf extract by the appropriate extraction method,” Industrial Crops and Products, vol. 44, pp. 566–571, 2013. View at: Publisher Site | Google Scholar
  24. Y.-F. Chu, J. Sun, X. Wu, and R. H. Liu, “Antioxidant and antiproliferative activities of common vegetables,” Journal of Agricultural and Food Chemistry, vol. 50, no. 23, pp. 6910–6916, 2002. View at: Publisher Site | Google Scholar
  25. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, Oxford, UK, 3rd edition, 1999.
  26. S. C. Sikka and W. J. G. Hellstrom, “Role of oxidative stress and antioxidants in Peyronie's disease,” International Journal of Impotence Research, vol. 14, no. 5, pp. 353–360, 2002. View at: Publisher Site | Google Scholar
  27. A. Zamblé, D. Yao, F. Martin-Nizard et al., “Vasoactivity and antioxidant properties of Microdesmis keayana roots,” Journal of Ethnopharmacology, vol. 104, no. 1-2, pp. 263–269, 2006. View at: Publisher Site | Google Scholar
  28. O. V. Evgenov and L. Liaudet, “Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock,” Current Vascular Pharmacology, vol. 3, no. 3, pp. 293–299, 2005. View at: Publisher Site | Google Scholar
  29. L.-Y. Zang, G. Cosma, H. Gardner, V. Castranova, and V. Vallyathan, “Effect of chlorogenic acid on hydroxyl radical,” Molecular and Cellular Biochemistry, vol. 247, no. 1-2, pp. 205–210, 2003. View at: Publisher Site | Google Scholar
  30. M. Rajasekaran, W. J. G. Hellstrom, and S. C. Sikka, “Nitric oxide induces oxidative stress and mediates cytotoxicity to human cavernosal cells in culture,” Journal of Andrology, vol. 22, no. 1, pp. 34–39, 2001. View at: Google Scholar
  31. E. Díaz-Díaz, M. C. León, N. O. Arzuaga et al., “Erectile dysfunction: a chronic complication of the diabetes mellitus,” in Erectile Dysfunction—Disease-Associated Mechanisms and Novel Insights into Therapy, K. Nunes, Ed., InTech, 2012. View at: Google Scholar
  32. C. Szabó, H. Ischiropoulos, and R. Radi, “Peroxynitrite: biochemistry, pathophysiology and development of therapeutics,” Nature Reviews Drug Discovery, vol. 6, no. 8, pp. 662–680, 2007. View at: Publisher Site | Google Scholar
  33. A. Agarwal, K. C. Nandipati, R. K. Sharma, C. D. Zippe, and R. Raina, “Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction,” Journal of Andrology, vol. 27, no. 3, pp. 335–347, 2006. View at: Publisher Site | Google Scholar
  34. G. Gilman, The Pharmacological Basis of Therapeutics, McGraw-Hill, 11th edition, 2006.
  35. R. Sarkar, B. Hazra, and N. Mandal, “Hepatoprotective potential of Caesalpinia crista against iron-overload-induced liver toxicity in mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 896341, 9 pages, 2012. View at: Publisher Site | Google Scholar
  36. G. Sen, S. Mukhopadhyay, M. Ray, and T. Biswas, “Quercetin interferes with iron metabolism in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 5, pp. 1066–1075, 2008. View at: Publisher Site | Google Scholar
  37. S. F. Akomolafe, G. Oboh, A. A. Akindahunsi, and A. J. Afolayan, “Tetracarpidium conophorum (Mull.Arg) Hutch & Dalziel inhibits FeSO4-induced lipid peroxidation in rat’s genitals,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article 57, 2015. View at: Publisher Site | Google Scholar
  38. C. M. Ryu, M. A. Farag, C. H. Hu et al., “Bacterial volatiles promote growth in Arabidopsis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, pp. 4927–4932, 2003. View at: Google Scholar
  39. K. M. Azadzoi and M. Siroky, “Oxidative stress and molecular reactions in arteriogenic erectile dysfunction,” Chonnam Medical Journal, vol. 45, no. 1, pp. 1–8, 2009. View at: Publisher Site | Google Scholar
  40. G. Oboh, R. L. Puntel, and J. B. T. Rocha, “Hot pepper (Capsicum annuum, tepin and Capsicum chinese, habanero) prevents Fe2+-induced lipid peroxidation in brain—in vitro,” Food Chemistry, vol. 102, no. 1, pp. 178–185, 2007. View at: Publisher Site | Google Scholar
  41. S. Szymonik-Lesiuk, G. Czechowska, M. Stryjecka-Zimmer et al., “Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 10, no. 4, pp. 309–315, 2003. View at: Publisher Site | Google Scholar
  42. X. Jia, C. Han, and J. Chen, “Effects of tea on preneoplastic lesions and cell cycle regulators in rat liver,” Cancer Epidemiology, Biomarkers & Prevention, vol. 11, no. 12, pp. 1663–1667, 2002. View at: Google Scholar
  43. K. K. Khanna and S. P. Jackson, “DNA double-strand breaks: signaling, repair and the cancer connection,” Nature Genetics, vol. 27, no. 3, pp. 247–254, 2001. View at: Publisher Site | Google Scholar
  44. S. Doumas, M. Doumas, A. Tsakiris, and C. Zamboulis, “Male and female sexual dysfunction: is hypertension an innocent bystander or a major contributor,” Revista Brasileira de Hipertensão, vol. 14, pp. 139–147, 2007. View at: Google Scholar
  45. J. Stefan and R. E. Schmieder, “Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia,” Current Hypertension Reports, vol. 5, no. 3, pp. 199–207, 2003. View at: Publisher Site | Google Scholar
  46. B. H. Kim, H. S. Park, H. J. Kim et al., “Enrichment of microbial community generating electricity using a fuel-cell-type electrochemical cell,” Applied Microbiology and Biotechnology, vol. 63, no. 6, pp. 672–681, 2004. View at: Publisher Site | Google Scholar
  47. E. R. Da Silva, C. D. C. Maquiaveli, and P. P. Magalhães, “The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase,” Experimental Parasitology, vol. 130, no. 3, pp. 183–188, 2012. View at: Publisher Site | Google Scholar
  48. M. B. G. Dos Reis, L. C. Manjolin, C. D. C. Maquiaveli, O. A. Santos-Filho, and E. R. da Silva, “Inhibition of Leishmania (Leishmania) amazonensis and rat arginases by green tea EGCG, (+)-catechin and (-)-epicatechin: a comparative structural analysis of enzyme-inhibitor interactions,” PLoS ONE, vol. 8, no. 11, Article ID e78387, 2013. View at: Publisher Site | Google Scholar

Copyright © 2015 Ganiyu Oboh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

4507 Views | 1483 Downloads | 42 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.